• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Record Earnings Might Change The Case For Investing In CME (CME)

    Simply Wall St·10/23/2026 13:46:12
    语音播报
    • CME Group reported third quarter 2026 revenue of US$1,737.3 million and net income of US$1,036.9 million, with earnings per share ahead of analyst expectations, supported by record average daily volumes and new contracts across all six asset classes.
    • The exchange is leaning into product breadth, adding Bitcoin Cash and Uniswap futures, new European dairy contracts, and planned tungsten futures, which broadens fee pools across crypto, commodities and agricultural markets.
    • This article examines how CME Group's investment narrative is influenced by record Q3 volumes and earnings from a wider product mix.

    Scan exchanges riding similar volume and product momentum as CME Group through a curated set of 30 resilient stocks with low risk scores that still aim to keep risk scores in check.

    CME Group Investment Narrative Recap

    To own CME Group, you need to believe it can keep being the preferred venue for hedging rates, equity indexes, commodities and crypto while broadening into new contracts without eroding its economics. The latest quarter supports that view, with record Q3 revenue, strong earnings per share and volume strength across all six asset classes.

    The near term swing factor is whether elevated trading activity and recent fee tweaks hold up enough to sustain current earnings power. The biggest risk remains competitive pressure in benchmark contracts and crypto derivatives, where any share loss or regulatory shift could put CME Group’s growth, margins and valuation under closer scrutiny.

    Among the recent announcements, the first block trades in Bitcoin Cash and Uniswap futures are most tied to this earnings story. They plug directly into CME Group’s single asset crypto suite, which already spans Bitcoin, Ether and several altcoins, and they build on management’s push into 24/7 access and broader digital asset hedging.

    Execution here matters because crypto related contracts sit at the intersection of two key issues for CME Group: product led volume catalysts and regulatory risk around perpetual futures and leverage. Strong, regulated volume in listed crypto futures can reinforce the exchange’s role with institutions, although ongoing disputes about how perps are classified still hang over this part of the portfolio.

    CME Group's analyst narrative points to forecast revenue of US$8.0b and earnings of US$4.6b by 2029, based on an assumed 5.6% yearly increase in revenue and an earnings uplift of about US$0.3b from current earnings of US$4.3b.

    Uncover why CME Group's fair value indicates a 5% potential downside to its current price, leaving little room for error.

    NasdaqGS:CME 1-Year Stock Price Chart
    NasdaqGS:CME 1-Year Stock Price Chart

    Exploring Other Perspectives

    Three fair value estimates from the Simply Wall St Community span roughly US$246 to US$313 per share, so retail opinions on CME Group already cover a wide band before factoring in record Q3 results, fresh crypto futures and new European dairy contracts. When you then consider competition and crypto regulation risks, there are plenty of reasons to test several alternative viewpoints for yourself.

    Explore 2 other CME Group fair value estimates, including one that suggests as much as 20% downside from the current price.

    Reach Your Own Conclusion

    Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

    Looking For More Investment Ideas Beyond CME Group?

    If CME Group has sharpened your thinking about market infrastructure, use that momentum to build a broader watchlist across different themes and risk levels.